Skip to main content
. 2024 Oct 29;15:1480506. doi: 10.3389/fimmu.2024.1480506

Figure 1.

Figure 1

Number of participants with rheumatic disease (RD) who underwent T-SPOT.TB® in HTLV-1 RD Miyazaki Registry. This registry enrolled 47 patients. Of the 47 patients, 44 underwent T-SPOT.TB® assay during their clinical course. These 44 patients were categorized into two groups according to the T-SPOT.TB® assay results as valid and invalid groups.